A Phase 2, Randomized, Double-blind, Placebo Controlled Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy

Sadick Research Group, New York

Stony Brook University Medical Center, Stony Brook

Charlottesville Dermatology, Charlottesville

Dermatology Research Institute, Coral Gables

Kenneth Beer, MD PA, West Palm Beach

Tennessee Clinical Research Center, Nashville

Mercy Health Research, Washington

ATS Clinical Research, Santa Monica

Dermatology Cosmetic Laser Medical Associates of La Jolla, San Diego

Premier Clinical Research, Spokane